Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People (male or female) who have been diagnosed with stage II or III breast cancer that is hormone receptor positive and HER2-negative, confirmed by a tissue biopsy, and who have already received full curative treatment for it
- People who are 18 years of age or older at the time they start taking the study medication ribociclib
- People who have been prescribed a combination of ribociclib and a type of hormone-blocking medicine called an aromatase inhibitor (AI), with or without an additional hormone-suppressing injection, no more than 28 days before agreeing to join the study
- People for whom hormone therapy with an aromatase inhibitor (with or without a hormone-suppressing injection) was started no earlier than 12 months before beginning ribociclib
- People who are willing and able to provide written agreement to participate in the study
Who may not be able to join:
- People who are already taking part in another clinical trial that involves a medical treatment or intervention at the time of joining this study
- People who are currently receiving active treatment for a cancer other than breast cancer at the time of enrollment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +41613241111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number (%) of patients who remain on treatment with ribociclib + AI over the 12 months period
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.